Literature DB >> 10100569

Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD.

A A Bhave1, K Thirunavukkarasu, D J Gottlieb, K Bradstock.   

Abstract

We describe a case of disseminated nocardiosis in a 53-year-old male allogeneic marrow recipient with chronic GVHD, 15 years post BMT. Six months prior to admission he was treated for recurrent chronic GVHD with corticosteroids with a good response. He deteriorated subsequently while still on steroids requiring admission for fever, anorexia, weight loss, productive cough and progressive dyspnoea. On admission he had multiple nodular lesions on chest roentgenogram and subsequently grew Nocardia farcinica in blood culture. N. farcinica is rare post BMT, has a high mortality, is resistant to various antibiotics and needs prolonged antimicrobial therapy. We report the successful management of our patient with single agent trimethoprim-sulphamethoxazole.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10100569     DOI: 10.1038/sj.bmt.1701602

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Pulmonary Nocardiosis.

Authors:  Gio J. Baracco; Gordon M. Dickinson
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.663

2.  An Unusual Presentation of Nocardiosis in an Allogeneic Transplant Recipient.

Authors:  Uroosa Ibrahim; Amina Saqib; Farhan Mohammad; Terenig Terjanian
Journal:  Cureus       Date:  2016-10-17

3.  Fatal Nocardia farcinica Bacteremia Diagnosed by Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry in a Patient with Myelodysplastic Syndrome Treated with Corticosteroids.

Authors:  Christian Leli; Amedeo Moretti; Francesco Guercini; Angela Cardaccia; Leone Furbetta; Giancarlo Agnelli; Francesco Bistoni; Antonella Mencacci
Journal:  Case Rep Med       Date:  2013-04-16

Review 4.  Nocardiosis in transplant recipients.

Authors:  D Lebeaux; E Morelon; F Suarez; F Lanternier; A Scemla; P Frange; J-L Mainardi; M Lecuit; O Lortholary
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-23       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.